background
dengu
viru
endem
peninsular
malaysia
clinic
manifest
vari
depend
incub
period
viru
well
immun
patient
dehydrogenas
defici
preval
malaysia
incid
note
individu
suffer
sever
clinic
present
dengu
infect
studi
aim
investig
oxid
respons
monocyt
individu
methodolog
monocyt
individu
infect
infect
rate
level
oxid
speci
nitric
oxid
superoxid
anion
oxid
stress
determin
compar
normal
control
princip
find
monocyt
individu
exhibit
significantli
higher
infect
rate
compar
normal
control
effort
explain
reason
enhanc
suscept
investig
product
monocyt
individu
defici
compar
normal
control
found
level
significantli
lower
denvinfect
monocyt
individu
compar
normal
control
furthermor
overal
oxid
stress
denvinfect
monocyt
individu
significantli
higher
compar
normal
control
correl
studi
denvinfect
cell
oxid
state
monocyt
confirm
find
dengu
infect
among
lead
caus
morbid
mortal
tropic
subtrop
mani
million
peopl
infect
death
yearli
dengu
infect
caus
dengu
viru
denv
rna
viru
famili
flavivirida
four
serotyp
viru
refer
four
serotyp
caus
full
spectrum
diseas
denv
primarili
transmit
human
bite
infect
aed
mosquito
particularli
aed
aegypti
aed
speci
transmit
diseas
includ
albopictu
polynesiensi
scutellari
although
uncommon
denv
also
transmit
via
infect
blood
product
organ
transplant
larg
percentag
peopl
infect
denv
show
mild
symptom
fever
hand
patient
experi
sever
ill
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
life
threaten
sever
factor
associ
develop
sever
dengu
includ
prior
infect
heterotyp
serotyp
strain
infect
viru
age
gender
genet
background
patient
denvrel
ill
common
children
contrast
infect
wellnourish
children
predispos
sever
ill
polymorph
gene
code
tumor
necrosi
factor
alpha
tnfa
mannanbind
lectin
cytotox
tlymphocyt
antigen
transform
growth
factor
b
tgfb
dcsign
human
leukocyt
antigen
hla
class
ii
allel
link
increas
risk
sever
dengu
complic
yet
anoth
genet
abnorm
report
link
dhfdss
defici
dehydrogenas
ubiquit
xlink
enzym
part
innat
defens
mechan
defici
common
enzymopathi
worldwid
highest
preval
among
subsaharan
african
countri
high
frequenc
defici
also
report
southeast
asian
countri
defici
affect
product
reactiv
nitrogen
rn
oxygen
speci
ro
nitric
oxid
superoxid
hydrogen
peroxid
h
result
alter
normal
redox
state
cell
cell
immun
system
employ
rn
ro
kill
invad
pathogen
reduct
redox
state
immun
cell
may
render
immun
cell
less
effect
invad
organ
result
increas
sever
infect
found
monocyt
patient
show
increas
suscept
infect
higher
replic
abil
normal
control
although
appear
connect
defici
enhanc
denv
replic
studi
carri
elucid
molecular
mechan
behind
observ
present
studi
aim
find
whether
alter
redox
state
monocyt
individu
respons
increas
suscept
monocyt
enhanc
denv
replic
studi
approv
research
ethic
committe
clinic
research
center
crc
ministri
health
research
ethic
committe
univers
sain
malaysia
studi
carri
januari
decemb
written
inform
consent
obtain
blood
donor
agre
particip
studi
standard
inclus
criterion
blood
donor
follow
male
donor
includ
addit
donor
prior
histori
denv
infect
exclud
blood
donat
portion
ml
blood
tube
blood
bag
taken
blood
screen
defici
use
ultraviolet
test
cat
sqmmr
r
system
athenagreec
activ
assay
use
kit
cat
randox
laboratori
antrim
uk
follow
manufactur
protocol
donor
without
defici
screen
select
control
sera
donor
screen
denvreact
antibodi
use
iggigm
captur
elisa
kit
igm
cat
igg
cat
panbio
brisban
australia
accord
manufactur
protocol
mosquito
albopictu
cell
line
atcc
usa
use
propag
kindli
provid
prof
shamala
univers
malaya
leibovitz
cultur
medium
sigma
usa
supplement
lglutamin
sigma
usa
tryptos
phosphat
broth
hi
media
india
penicillinstreptomycin
gibco
grand
island
usa
fetal
bovin
serum
fb
gibco
grand
island
usa
condit
medium
titrat
use
plaqu
assay
vero
cell
atcc
usa
essenti
describ
previous
store
aliquot
peripher
blood
mononuclear
cell
pbmc
isol
normal
control
blood
densiti
gradient
centrifug
use
lymphoprep
medium
cat
axi
shield
norway
follow
manufactur
protocol
pbmc
use
isol
primari
monocyt
use
mac
kit
system
ii
cat
miltenyibiotec
gmbh
gladbach
germani
purifi
monocyt
enumer
cell
viabil
determin
trypan
blue
exclus
assay
cell
seed
plate
costar
corn
usa
cellswel
maintain
humidifi
incub
presenc
co
monocyt
normal
control
infect
multipl
infect
moi
hour
co
describ
previous
optim
viru
contact
monocyt
plate
gentli
agit
everi
min
hour
incub
cell
wash
twice
serumfre
medium
resuspend
complet
growth
medium
cultur
co
five
day
mockinfect
monocyt
cultur
set
simultan
neg
control
condit
media
harvest
variou
time
point
hour
postinfect
number
infect
cell
viru
titer
determin
use
flow
estim
million
case
dengu
fever
occur
year
worldwid
among
case
lifethreaten
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
factor
contribut
develop
dhfdss
yet
fulli
identifi
dehydrogenas
defici
preval
southeast
asian
countri
dengu
also
endem
besid
affect
normal
function
erythrocyt
defici
also
affect
cell
caus
abnorm
cellular
redox
alter
redox
state
cell
may
render
less
effect
clear
microbi
viral
infect
confirm
previou
find
monocyt
individu
support
better
dengu
viru
replic
addit
show
reduc
product
reactiv
oxygen
nitrogen
speci
elev
level
oxid
stress
respons
enhanc
viral
replic
suggest
redox
imbal
observ
infect
monocyt
individu
may
facilit
dengu
transmiss
affect
clinic
outcom
howev
hand
studi
carri
area
defici
dengu
endem
reveal
statist
signific
correl
sever
dengu
defici
welldesign
studi
need
demonstr
individu
risk
sever
dengu
cytometri
plaqu
assay
respect
viruscontain
condit
media
store
aliquot
infect
mockinfect
monocyt
harvest
wash
twice
cold
phosphat
buffer
salin
pb
contain
nan
sigmausa
surfac
label
perform
incub
cell
ml
dilut
mab
cat
becton
dickinson
san
jose
ca
unit
state
min
ice
dark
cell
fix
permeabil
ml
cytofixcytoperm
solut
bd
bioscienc
san
diego
ca
min
room
temperatur
follow
cytoperm
cytowash
solut
cell
stain
ml
dilut
e
proteinspecif
monoclon
antibodi
abcam
incub
hour
ice
dark
wash
twice
cytopermcytowash
solut
secondari
fitclabel
goat
antimouseigg
cat
becton
dickinson
bioscienc
usa
antibodi
ad
final
concentr
mg
ml
incub
minut
ice
dark
final
cell
wash
twice
cytopermcytowash
solut
resuspend
ml
paraformaldehyd
contain
nan
subject
flow
cytometri
mockinfect
monocyt
use
neg
control
treat
run
simultan
infect
group
monocyt
improv
gate
setup
compens
precis
measur
minimum
event
acquir
use
fac
calibur
ii
flow
cytomet
becton
dickinson
bioscienc
usa
data
analyz
use
flow
softwar
ver
turku
center
biotechnolog
univers
turku
finland
http
wwwflowingsoftwarecom
isotypematch
antibodi
use
neg
control
percentag
posit
cell
determin
fitc
fluoresc
histogram
use
region
defin
base
analysi
mockinfect
control
cell
dengu
viru
particl
titrat
plaqu
assay
previous
describ
roehrig
jt
et
al
briefli
vero
cell
seed
plate
densiti
cellswel
complet
dmem
medium
without
phenol
red
incub
overnight
co
serial
dilut
viruscontain
supernat
fb
ad
well
incub
co
minut
gentl
agit
everi
minut
medium
care
remov
cell
overlaid
ml
fb
contain
carboxymethylcellulos
cmc
sigma
usa
incub
co
day
cmc
remov
wash
well
twice
ml
pbswell
cell
fix
freshli
prepar
cold
paraformaldehyd
stain
crystal
violet
amresco
usa
ethanol
minut
viral
titer
express
plaqu
form
unit
pfu
ml
number
plaqu
per
well
dilut
inoculum
volum
nitric
oxid
releas
condit
media
mockinfect
monocyt
determin
measur
stabl
nitrit
use
greiss
reagent
assay
kit
cat
r
system
accord
manufactur
protocol
absorb
measur
nm
use
bio
mate
thermo
scientif
usa
spectrophotomet
measur
perform
duplic
intracellular
superoxid
anion
ro
product
quantifi
infect
control
cell
use
total
rossuperoxid
detect
kit
cat
enz
enzo
life
scienc
inc
usa
follow
manufactur
protocol
briefli
control
cell
harvest
hour
wash
use
ro
buffer
suppli
kit
posit
neg
control
cell
incub
ml
rossuperoxid
detect
reagent
minut
co
fb
subject
flow
cytometri
analysi
data
analysi
anticip
result
obtain
gener
log
xaxi
versu
log
yaxi
dot
plot
quadrant
ad
monocyt
increas
product
superoxid
demonstr
bright
orang
fluoresc
detect
use
channel
appear
two
upper
quadrant
log
xaxi
versu
log
yaxi
dot
plot
monocyt
high
product
oxid
stress
demonstr
bright
green
fluoresc
regist
channel
appear
upper
lower
right
quadrant
log
xaxi
versu
log
yaxi
dot
plot
result
experi
present
percentag
cell
increas
superoxid
ro
product
increas
mean
fluoresc
induc
sampl
versu
control
result
report
mean
sd
data
analyz
use
spss
softwar
version
pvalu
calcul
use
student
test
pvalu
less
consid
signific
error
bar
express
mean
sd
four
hundr
blood
donor
screen
enzym
defici
donor
found
defici
ultraviolet
test
donor
match
age
year
year
select
normal
control
donor
defici
n
agematch
donor
n
subject
enzym
activ
assay
donor
refer
normal
control
hereaft
individu
less
normal
activ
measur
fluorometr
assay
mean
activ
individu
iug
hb
significantli
lower
mean
activ
match
normal
control
iug
hb
shown
fig
monocyt
cultur
increas
infect
cell
rate
detect
flow
cytometri
hour
postinfect
peak
valu
reach
peak
percentag
infect
cell
decreas
fig
monocyt
subject
show
mean
viru
infect
percentag
hour
post
infect
normal
control
monocyt
cultur
frequenc
infect
cell
increas
hour
postinfect
peak
valu
reach
follow
decreas
fig
monocyt
normal
control
show
mean
viru
infect
percentag
hour
post
infect
result
indic
mean
percentag
monocyt
subject
exceed
percentag
monocyt
normal
control
differ
infect
cell
two
group
statist
signific
moreov
peak
infect
delay
hour
monocyt
normal
control
compar
monocyt
subject
data
verifi
measur
cellfre
supernat
infect
monocyt
cultur
fig
monocyt
cultur
increas
titer
detect
plaqu
assay
hour
post
infect
peak
valu
reach
time
point
titer
decreas
fig
releas
monocyt
cultur
show
mean
peak
titer
pfuml
hour
post
infect
normal
control
monocyt
cultur
increas
titer
detect
hour
post
infect
peak
valu
reach
time
point
titer
decreas
fig
releas
normal
control
monocyt
cultur
show
mean
peak
titer
pfuml
hour
post
infect
result
indic
significantli
releas
infect
monocyt
subject
compar
infect
monocyt
normal
control
peak
titer
detect
earlier
time
point
hour
post
infect
monocyt
cultur
compar
normal
control
monocyt
cultur
hour
post
infect
illustr
fig
infect
induc
product
normal
control
monocyt
time
depend
manner
monocyt
cultur
increas
produc
hour
post
infect
peak
valu
reach
follow
decreas
fig
releas
monocyt
cultur
show
mean
peak
level
mm
l
hour
postinfect
hand
normal
control
monocyt
increas
produc
hour
postinfect
peak
valu
reach
fig
releas
normal
control
monocyt
show
mean
peak
level
mm
l
hour
postinfect
differ
level
produc
normal
control
monocyt
signific
peak
level
detect
earlier
time
point
hour
post
infect
monocyt
cultur
compar
normal
control
monocyt
cultur
hour
post
infect
lower
level
endogen
product
induc
infect
monocyt
correl
acceler
replic
cell
shown
fig
infect
monocyt
induc
gener
superoxid
anion
normal
control
monocyt
time
depend
manner
monocyt
cultur
increas
level
observ
hour
post
infect
peak
valu
reach
fig
hand
normal
control
monocyt
cultur
level
increas
hour
postinfect
peak
valu
reach
fig
result
indic
significantli
less
gener
infect
monocyt
subject
compar
infect
normal
control
monocyt
oxid
stress
monocyt
normal
control
display
fig
infect
monocyt
induc
oxid
stress
accumul
normal
control
monocyt
time
depend
manner
monocyt
cultur
oxid
stress
accumul
increas
hour
post
infect
peak
level
reach
fig
convers
normal
control
monocyt
cultur
oxid
stress
accumul
increas
hour
postinfect
peak
valu
reach
fig
result
indic
significantli
oxid
stress
accumul
infect
monocyt
subject
compar
infect
monocyt
normal
control
peak
oxid
stress
accumul
notic
earlier
time
point
hour
post
infect
monocyt
cultur
compar
normal
control
monocyt
cultur
hour
post
infect
higher
earlier
accumul
oxid
stress
monocyt
appear
result
greater
viral
replic
cell
compar
normal
control
monocyt
signific
strong
posit
correl
r
p
cell
level
monocyt
subject
fig
compar
monocyt
normal
control
fig
signific
moder
posit
correl
r
p
cell
level
monocyt
subject
fig
compar
monocyt
normal
control
fig
also
signific
moder
posit
correl
r
p
cell
level
monocyt
subject
fig
compar
monocyt
normal
control
fig
correl
studi
support
hypothesi
oxid
state
cell
may
contribut
enhanc
denv
infect
denv
caus
infect
may
rang
mild
sever
affect
patient
sever
form
associ
dhf
dss
life
threaten
factor
defin
progress
toward
sever
form
dhfdss
dengu
infect
remain
elucid
one
possibl
correl
though
may
innat
defici
common
enzymopathi
worldwid
pentos
phosphat
pathway
ppp
provid
reduc
form
nadph
variou
cellular
reaction
includ
glutathion
gsh
recycl
superoxid
anion
product
via
nadph
oxidas
nitric
oxid
synthesi
cholesterol
synthesi
inhibit
result
gener
less
reactiv
oxygen
nitrogen
speci
superoxid
anion
hydrogen
peroxid
hydroxyl
radic
granulocyt
endotheli
cell
recurr
microbi
infect
defici
individu
report
effect
cellular
redox
state
cours
viral
infect
also
well
document
instanc
replic
corona
viru
coxsacki
viru
rhinoviru
influenza
hiv
hepat
enteroviru
viru
modul
redox
milieu
coxsacki
virus
found
replic
higher
titer
mice
fed
diet
defici
selenium
se
vitamin
e
mice
given
normal
diet
similarli
glutathion
administr
exhibit
antivir
effect
influenza
viru
find
suggest
redox
imbal
may
conduc
enhanc
replic
virul
certain
virus
chao
et
al
report
monocyt
patient
use
ex
vivo
cultur
system
readili
infect
two
strain
new
guinea
c
strain
df
patient
strain
dhf
figur
oxid
stress
accumul
denvinfect
monocyt
normal
control
accumul
oxid
stress
monocyt
normal
control
donor
increas
significantli
infect
timedepend
manner
monocyt
subject
accumul
significantli
higher
oxid
stress
compar
monocyt
normal
control
figur
correl
replic
oxid
stress
monocyt
normal
control
signific
moder
strong
correl
found
infect
monocyt
oxid
state
oxid
stress
monocyt
individu
compar
normal
control
b
patient
normal
control
howev
underli
mechan
enhanc
suscept
investig
confirm
chao
find
show
addit
reduc
product
well
earlier
accumul
oxid
stress
contribut
significantli
enhanc
infect
monocyt
subject
enhanc
infect
monocyt
denv
may
attribut
increas
viral
receptor
cell
greater
product
viral
particl
combin
studi
upregul
viral
receptor
clearli
see
enhanc
product
viral
particl
cell
base
find
report
other
propos
model
associ
redox
statu
host
cell
denv
follow
entri
cell
denv
fuse
endosom
membran
releas
nucleocapsid
cytoplasm
viral
rna
replic
translat
protein
process
may
affect
cellular
redox
state
effici
oxid
environ
thu
result
enhanc
viru
product
find
chao
et
al
one
present
suggest
high
compet
denv
infect
monocyt
individu
may
result
increas
replic
higher
viru
yield
higher
viral
load
individu
may
increas
probabl
dengu
transmiss
other
via
infect
mosquito
sever
report
shown
correl
sever
dengu
high
viral
load
defici
report
caus
granulocyt
dysfunct
combin
granulocyt
dysfunct
enhanc
replic
denv
monocyt
individu
may
prevent
clear
primari
infect
thu
predispos
infect
individu
sever
form
diseas
remain
seen
whether
deficiencymedi
enhanc
viral
replic
outcom
sever
dengu
infect
area
dengu
infect
defici
endem
thailand
preval
defici
gener
popul
approxim
cohort
male
diagnos
dhf
studi
determin
defici
relat
occurr
andor
cours
dengu
infect
total
dhf
patient
defici
thu
signific
associ
establish
defici
dhf
howev
studi
base
modest
number
hospit
patient
therefor
provid
littl
inform
incid
sever
dengu
defici
individu
high
preval
also
report
african
popul
low
incid
sever
dengu
note
popul
african
origin
coupl
studi
conduct
cuba
haiti
sinc
outcom
studi
inconclus
welldesign
studi
need
demonstr
whether
individu
risk
sever
dengu
statist
signific
studi
would
potenti
benefici
provid
ad
knowledg
host
defens
mechan
may
clinic
import
individu
travel
live
denv
endem
area
